Axxam
Axxam's Overview
Axxam, now part of Certara, is a premier contract research organization (CRO) and discovery company renowned for its expertise in early-stage drug discovery. For over two decades, Axxam has provided integrated services including assay development, high-throughput screening (HTS), hit identification, and hit-to-lead optimization. Leveraging cutting-edge technologies and a vast compound library, Axxam supports pharmaceutical companies, biotechs, and academic institutions worldwide in accelerating their research pipelines. Their core capabilities span various target classes and therapeutic areas, with a strong focus on innovative biological assays and electrophysiology.
Where is Axxam's Headquarters?
HQ Function
Serves as the central hub for Axxam's research and development, laboratory operations (including HTS, assay development, electrophysiology), business development, and corporate administration.
Notable Features:
Located within OpenZone, a major Italian scientific campus dedicated to Life Sciences, fostering collaboration and innovation. The facility houses state-of-the-art laboratories equipped for advanced drug discovery research.
Work Culture:
Axxam fosters a scientifically driven, collaborative, and innovative work environment. Employees are focused on precision and quality in research. Being part of the OpenZone campus promotes interaction with a broader scientific community.
HQ Significance:
The headquarters is critical for Axxam's core service delivery, housing its advanced technological platforms (e.g., automated screening systems, electrophysiology rigs), expert scientific teams, and extensive compound libraries essential for early-stage drug discovery projects.
Values Reflected in HQ: The state-of-the-art facility and its location in a dedicated science park reflect Axxam's commitment to scientific excellence, cutting-edge innovation, collaboration, and high-quality research services in drug discovery.
Location:
Axxam supports a global clientele, including major pharmaceutical and biotechnology companies as well as academic institutions across Europe, North America, and Asia. Its specialized early-stage drug discovery services, such as HTS, assay development, compound profiling, and electrophysiology, are delivered to international partners from its advanced facilities in Italy. Since its acquisition by Certara in 2024, Axxam's global reach and collaborative capabilities are further enhanced through Certara's extensive international network.
Street Address:
Via Antonio Meucci 3
City:
Bresso (MI)
State/Province:
Lombardy
Country:
Italy
Axxam's Global Presence
Buying Intent Signals for Axxam
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Axxam
As of April 2025, Axxam' leadership includes:
Investors of Axxam
Axxam has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
The most significant leadership-related event for Axxam in the last 12 months was its acquisition by Certara in February 2024. This resulted in the integration of Axxam's management and team into the Certara organization. Specific high-profile individual executive hires or departures from Axxam's core team have not been prominently announced beyond this broader organizational transition.
Technology (Tech Stack) used by Axxam
Discover the tools Axxam uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Axxam Email Formats and Examples
Axxam commonly uses the email format combining an employee's first name and last name, separated by a dot, followed by the company domain. This is a standard professional format.
first.last@axxam.com
Format
stefan.lohmer@axxam.com
Example
90%
Success rate
News and media
Certara Website • February 1, 2024
Axxam Acquired by Certara to Expand Early Drug Discovery Capabilities
Certara, a global leader in model-informed drug development, announced its acquisition of Axxam S.p.A. This strategic move enhances Certara's capabilities in early-stage drug discovery, particularly in HTS, assay development, and hit identification. Axxam's team and facilities in Bresso, Italy, will be integrated into Certara's operations....more
European Biotechnology Magazine • November 20, 2023
Axxam Collaborates with AliX Srl to Discover Novel Small Molecules Targeting RNA
Axxam S.p.A. announced a research collaboration with AliX Srl, an Italian biotech startup, to identify and develop novel small molecules targeting RNA for diseases currently considered 'undruggable.' Axxam will utilize its HTS capabilities and small molecule libraries for this project....more
Axxam Website • January 25, 2024
Axxam Showcases Expertise at SLAS2024 International Conference and Exhibition
Axxam announced its participation in the SLAS2024 International Conference and Exhibition in Boston, MA. The company presented its latest advancements in drug discovery services, including HTS, hit identification, and electrophysiology, engaging with industry leaders and potential collaborators....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Axxam, are just a search away.